| Title | Cytotherapy |
| Abbreviation | Cytotherapy |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Transplantation (Q1); Cancer Research (Q2); Cell Biology (Q2); Genetics (clinical) (Q2); Immunology (Q2); Immunology and Allergy (Q2); Oncology (Q2) |
| h-index | 105 |
| Overall Rank/Ranking | 3867 |
| SCImago Journal Rank (SJR) | 1.084 |
| Impact Score | 3.60 |
| Publisher | Elsevier B.V. |
| Country | United States |
| ISSN | 14772566, 14653249 |
| Best Quartile | Q1 |
| Coverage History | 1999-2023 |
Cytotherapy is the official journal of the International Society for Cellular Therapy (ISCT). Coverage encompasses important new therapies emerging from the manipulation of cytokines and cells, as well as bringing readers the very latest developments news and opinion in the fast-moving field of vaccines, cytokine and cellular therapy. A particular emphasis is on the translation of research from the laboratory into clinical practice.
The journal’s scope includes research in:
- Stem cell processing and transplantation
- Cancer
- Stem cell plasticity
- Autoimmune diseases
- Immunotherapy
- Congenital disorders
- Novel molecular therapies
- Gene therapy
- Cell-based therapies of malignant and non-malignant blood diseases
Cytotherapy is a journal covering the technologies/fields/categories related to Transplantation (Q1); Cancer Research (Q2); Cell Biology (Q2); Genetics (clinical) (Q2); Immunology (Q2); Immunology and Allergy (Q2); Oncology (Q2). It is published by Elsevier B.V.. The overall rank of Cytotherapy is 3867. According to SCImago Journal Rank (SJR), this journal is ranked 1.084. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 105. The best quartile for this journal is Q1.
The ISSN of Cytotherapy journal is 14772566, 14653249. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Cytotherapy is cited by a total of 1252 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of Cytotherapy is 3.60, which is computed in 2024 as per its definition. Cytotherapy IF is decreased by a factor of 0.31 and approximate percentage change is -7.93% when compared to preceding year 2022, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of Cytotherapy is 3.60. If the same downward trend persists, Impact IF may fall in 2024 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 3.60 |
| 2022 | 3.91 |
| 2021 | 4.84 |
| 2020 | 4.21 |
| 2019 | 3.58 |
| 2018 | 3.82 |
| 2017 | 3.75 |
| 2016 | 3.28 |
| 2015 | 3.79 |
| 2014 | 3.50 |
Cytotherapy has an h-index of 105. It means 105 articles of this journal have more than 105 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Cytotherapy is 14772566, 14653249. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Cytotherapy is 3867. According to SCImago Journal Rank (SJR), this journal is ranked 1.084. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 1.084 |
| 2022 | 1.186 |
| 2021 | 1.004 |
| 2020 | 1.192 |
| 2019 | 1.233 |
| 2018 | 1.287 |
| 2017 | 1.144 |
| 2016 | 1.213 |
| 2015 | 1.315 |
| 2014 | 1.193 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 3867 |
| 2022 | 3142 |
| 2021 | 4092 |
| 2020 | 3336 |
| 2019 | 3104 |
| 2018 | 2941 |
| 2017 | 3594 |
| 2016 | 3313 |
| 2015 | 2975 |
| 2014 | 3349 |
Cytotherapy is published by Elsevier B.V.. It's publishing house is located in United States. Coverage history of this journal is as following: 1999-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Cytotherapy is Cytotherapy. This abbreviation ('Cytotherapy') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Transplantation (Q1); Cancer Research (Q2); Cell Biology (Q2); Genetics (clinical) (Q2); Immunology (Q2); Immunology and Allergy (Q2); Oncology (Q2), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Cytotherapy latest impact IF is 3.60. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 4.84 (2021) and 3.28 (2016), respectively, in the last 10 years. Moreover, its average IS is 3.83 in the previous 10 years.
The Cytotherapy has an SJR (SCImago Journal Rank) of 1.084, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 1.315 in 2015 and the lowest being 1.004 in 2021. Furthermore, the average SJR of the Cytotherapy over the previous 10-year period stands at 3.83.
The latest h-index of the Cytotherapy is 105.
The Cytotherapy is published by the Elsevier B.V., with its country of publication being the United States.
The Cytotherapy is currently ranked 3867 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 2941 in 2018 and its lowest position of 4092 in 2021.
The standard ISO4 abbreviation for the Cytotherapy is Cytotherapy.
Cytotherapy is classified as a journal that the Elsevier B.V. publishes.
The Cytotherapy encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Cytotherapy is assigned the following International Standard Serial Numbers (ISSN): 14772566, 14653249.
The best quartile for the Cytotherapy is Q1 (2023).
The Cytotherapy coverage history can be summarized as follows: 1999-2023.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Proceedings of the ASME Turbo Expo | conference and proceedings | 17577 | 54 | 0.00 | |
| Criminal Justice Review | journal | 12054 | SAGE Publications Inc. | 42 | 1.10 |
| Business Strategy Review | journal | 31512 | Wiley-Blackwell Publishing Ltd | 33 | 0.04 |
| British Journal of Special Education | journal | 16076 | Wiley-Blackwell Publishing Ltd | 44 | 0.78 |
| Syntax | journal | 3731 | Wiley-Blackwell Publishing Ltd | 33 | 0.93 |
| Rinsan Shikenj Oha/Journal of the Hokkaido Forest Products Research Institute | journal | 27272 | Hoikkaido Forest Products Research Institute | 4 | 0.00 |
| Metascience | journal | 24313 | Springer Nature | 3 | 0.00 |
| English Literary Renaissance | journal | 25777 | University of Chicago Press | 20 | 0.36 |
| American Journal of Immunology (discontinued) | journal | 19764 | Science Publications | 12 | 1.56 |
| Brain Imaging and Behavior | journal | 4615 | Springer New York | 68 | 2.72 |
| Year | Impact Score (IS) |
|---|---|
| 2024/2025 | Coming Soon |
| 2023 | 3.60 |
| 2022 | 3.91 |
| 2021 | 4.84 |
| 2020 | 4.21 |
| 2019 | 3.58 |
| 2018 | 3.82 |
| 2017 | 3.75 |
| 2016 | 3.28 |
| 2015 | 3.79 |
| 2014 | 3.50 |
